Which of the following drug products is exempt from the Poison Prevention Packaging Act?

The Poison Prevention Packaging Act (PPPA) aims to protect children from accidental poisoning by requiring that certain prescription and over-the-counter medications be packaged in child-resistant containers. However, certain products are exempt from this requirement due to their lower risk of causing harm in case of accidental ingestion.

In this case, potassium supplements that are packaged in unit dose packets are specifically exempt from the PPPA. This exemption is based on the fact that these products, especially when presented in unit dose forms, minimize the risk of accidental ingestion because the individual doses are designed to be taken all at once, which lessens the likelihood of children accessing or misusing the product.

Hydrochlorothiazide tablets, acetaminophen tablets, and ibuprofen capsules are all considered to pose a more significant risk of harm if ingested by children, thereby requiring child-resistant packaging to meet safety standards. Each of these medications has the potential for overdose and serious health consequences, making them subject to the packaging regulations of the PPPA.

Thus, unit dose packets of potassium supplements are recognized for their safety profile and are exempt from these stringent packaging requirements.